The HAIP is a small, implantable device placed under the skin that delivers chemotherapy directly to liver tumours via the hepatic artery.
1
The HAIP is a small, implantable device placed under the skin that delivers chemotherapy directly to liver tumours via the hepatic artery.
In a groundbreaking medical achievement, Burjeel Cancer Institute in Abu Dhabi has successfully performed the UAE’s first Hepatic Artery Infusion Pump (HAIP) surgery. This innovative procedure offers a new lease on life for patients with liver tumours, particularly those whose colorectal cancer has metastasized to the liver.
The HAIP is a small, implantable device placed under the skin that delivers chemotherapy directly to liver tumours via the hepatic artery. This targeted approach ensures higher concentrations of the drug reach the tumour site while minimizing systemic side effects such as nausea and fatigue. The procedure was conducted on a 60-year-old male patient, marking a significant advancement in cancer treatment in the region.
Dr. Mohammad Adileh, Head of Oncological Surgery at Burjeel Medical City, emphasized that this development places the UAE among leading nations offering such advanced treatments. The success of this operation not only improves patients’ chances of receiving curative surgical treatment but also enhances survival rates by providing more effective and localized therapy.
This achievement underscores the UAE’s commitment to adopting cutting-edge medical technologies and providing state-of-the-art cancer care within the country, reducing the need for patients to seek treatment abroad.
Keep in touch with our news & offers
